| Israel | Turquia | Áustria | |
| Radiocirurgia estereotáxica | de $19,000 | de $4,500 | de $17,000 |
A Bookimed não adiciona taxas extras aos preços de Radiocirurgia estereotáxica. As tarifas vêm das listas oficiais das clínicas. O pagamento é feito diretamente na clínica na chegada.
A Bookimed está comprometida com sua segurança. Trabalha apenas com instituições que mantêm altos padrões internacionais em Radiocirurgia estereotáxica e têm as licenças necessárias para atender pacientes internacionais em todo o mundo.
A Bookimed oferece assistência gratuita de especialistas. Um coordenador médico pessoal apoia antes, durante e após o tratamento, solucionando problemas. Nunca está sozinho em sua jornada de Radiocirurgia estereotáxica.
Dia 1
Dia 2
Dia 3
Dia 4
Dias 5-7
Semana 2
Por favor, note que este é um guia geral e casos individuais podem variar.
Prof. Zvi Cohen is Director of the Neurosurgery Department and the Neuro-Oncology Unit at Sheba Medical Center. He is a neurosurgeon and neuro-oncology expert. He was included in Forbes Israel’s Best Doctors 2025. He leads clinical research on drug therapies for malignant brain tumors. He also founded Sheba’s brain tumor tissue bank.
He is board-certified in neurosurgery. He trained at Tel Aviv University. He completed fellowships in neuroradiology at Beth Israel and in neurosurgical oncology at MD Anderson. His practice covers complex brain, pituitary, spine, and spinal cord tumors. He has expertise in stereotactic biopsies, image-guided resections, intraoperative MRI, navigation systems, and radiosurgery. He is a member of the Society for Neuro-Oncology and the Israeli Association of Neurological Surgeons.
Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.
He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.
His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.
He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.
Dr. Anton Wohl leads the Brain Tumors Unit at Sheba Medical Center (since 2026). He is a neurosurgeon specializing in neuro-oncology, brain tumor surgery, and stereotactic radiosurgery.
He performs complex tumor operations with intraoperative MRI and functional mapping. He also uses fluorescence guidance, neuronavigation, and awake craniotomy to help remove tumors safely and preserve function.
Accreditations: Israeli Board Certification in Neurosurgery; Israeli medical license; advanced international fellowships and training, including the Mayo Clinic (USA).
Research: author and co-author of peer-reviewed publications on glioblastoma, malignant brain tumors, radiosurgery, and experimental therapies.